Browse > Article

The Development of Dimerized Chicken Recombinant Single-chain Fv (ScFv) Antibody Using Leucine Zipper Motif  

Park, Dong-Woon (Department of Microbiology, College of Natural Sciences, Changwon National University)
Kim, Eon-Dong (Department of Microbiology, College of Natural Sciences, Changwon National University)
Kim, Sung-Heon (Department of Microbiology, College of Natural Sciences, Changwon National University)
Han, Jae-Yong (WCU Biomodulation Major, Department of Agricultural Biotechnology, and Research Institute for Agriculture and Life Sciences, Seoul National University)
Kim, Jin-Kyoo (Department of Microbiology, College of Natural Sciences, Changwon National University)
Publication Information
Korean Journal of Microbiology / v.47, no.4, 2011 , pp. 328-334 More about this Journal
Abstract
Leucine zipper motif consists of multiple periodic leucine residues, which forms amphipathic alpha helix. The hydrophobic nature of leucine zipper motif can dimerize proteins which contain this motif. Leucine zipper motif addition at C-terminus of single-chain Fv (ScFv) antibody induces its dimerization. Since the dimeric ScFv antibody contains two antigen binding sites (bivalency) like Y-shaped complete antibody, it could increase avidity. As a result, it could show higher antigen binding activity than monomeric ScFv antibodies. Based on this concept, monomeric chicken 8C3 ScFv antibody previously developed from chicken hybridoma was dimerized by the addition of leucine zipper motif at C-terminus of ScFv antibody. The dimeric 8C3 ScFv antibody specifically reacted with Eimerian sporozoite which causes Avian Coccidiosis. As expected, dimeric 8C3 ScFv antibody showed 3-folds higher antigen binding activity than monomer due to increased avidity. In addition, protien yields of dimer expression were 2-folds higher than monomer.
Keywords
avidity; dimer; leucine zipper motif; single-chain Fv antibody;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Albrecht, H., G.L. Denardo, and S.J. Denardo. 2006. Monospecific bivalent scFv-SH: effects of linker length and location of an engineered cysteine on production, antigen binding activity and free SH accessibility. J. Immunol. Methods 310, 100-116.   DOI
2 Bird, R.E., K.D. Hardman, J.W. Jacobson, S. Johnson, B.M. Kaufman, S.M. Lee, T. Lee, S.H. Pope, G.S. Riordan, and M. Whitlow. 1988. Single-chain antigen-binding proteins. Science 242, 423-426.   DOI
3 Brinkmann, U., M. Gallo, E. Brinkmann, S. Kunwar, and I. Pastan. 1993. A recombinant immunotoxin that is active on prostate cancer cells and that is composed of the Fv region of monoclonal antibody PR1 and a truncated form of Pseudomonas exotoxin. Proc. Natl. Acad. Sci. USA 90, 547-551.   DOI   ScienceOn
4 Brinkmann, U., Y. Reiter, S.H. Jung, B. Lee, and I. Pastan. 1993. A recombinant immunotoxin containing a disulfidestabilized Fv fragment. Proc. Natl. Acad. Sci. USA 90, 7538-7542.   DOI   ScienceOn
5 de Kruif, J. and T. Logtenberg. 1996. Leucine zipper dimerized bivalent and bispecific scFv antibodies from a semi-synthetic antibody phage display library. J. Biol. Chem. 271, 7630-7634.   DOI
6 Glockshuber, R., M. Malia, I. Pfitzinger, and A. Pluckthun. 1990. A comparison of strategies to stabilize immunoglobulin Fv-fragments. Biochemistry 29, 1362-1367.   DOI   ScienceOn
7 Huston, J.S., D. Levinson, M. Mudgett-Hunter, M.S. Tai, J. Novotny, M.N. Margolies, R.J. Ridge, R.E. Bruccoleri, E. Haber, R. Crea, and et al. 1988. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl. Acad. Sci. USA 85, 5879-5883.   DOI   ScienceOn
8 Kim, J.K., M.F. Tsen, V. Ghetie, and E.S. Ward. 1994. Identifying amino acid residues that influence plasma clearance of murine IgG1 fragments by site-directed mutagenesis. Eur. J. Immunol. 24, 542-548.   DOI   ScienceOn
9 Lawn, A.M. and M.E. Rose. 1982. Mucosal transport of Eimeria tenella in the cecum of the chicken. J. Parasitol. 68, 1117-23.   DOI   ScienceOn
10 Landschulz, W.H., P.F. Johnson, and S.L. McKnight. 1988. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 240, 1759-1764.   DOI
11 Muller, K.M., K.M. Arndt, and A. Pluckthun. 1998. A dimeric bispecific miniantibody combines two specificities with avidity. FEBS Lett. 432, 45-49.   DOI
12 O'Shea, E.K., R. Rutkowski, and P.S. Kim. 1989. Evidence that the leucine zipper is a coiled coil. Science 243, 538-542.   DOI
13 Verma, R., E. Boleti, and A.J. George. 1998. Antibody engineering: comparison of bacterial, yeast, insect and mammalian expression systems. J. Immunol. Methods 216, 165-181.   DOI
14 Pack, P., M. Kujau, V. Schroeckh, U. Knupfer, R. Wenderoth, D. Riesenberg, and A. Pluckthun. 1993. Improved bivalent miniantibodies, with identical avidity as whole antibodies, produced by high cell density fermentation of Escherichia coli. Biotechnology (NY) 11, 1271-1277.
15 Pack, P., K. Muller, R. Zahn, and A. Pluckthun. 1995. Tetravalent miniantibodies with high avidity assembling in Escherichia coli. J. Mol. Biol. 246, 28-34.   DOI   ScienceOn
16 Pack, P. and A. Pluckthun. 1992. Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli. Biochemistry 31, 1579-1584.   DOI   ScienceOn
17 Park, K.J., D.W. Park, C.H. Kim, B.K. Han, T.S. Park, J.Y. Han, H.S. Lillehoj, and J.K. Kim. 2005. Development and characterization of a recombinant chicken single-chain Fv antibody detecting Eimeria acervulina sporozoite antigen. Biotechnol. Lett. 27, 289-295.   DOI   ScienceOn
18 Schoonjans, R., A. Willems, S. Schoonooghe, J. Leoen, J. Grooten, and N. Mertens. 2001. A new model for intermediate molecular weight recombinant bispecific and trispecific antibodies by efficient heterodimerization of single chain variable domains through fusion to a Fab-chain. Biomol. Eng. 17, 193-202.   DOI   ScienceOn
19 Shan, D., O.W. Press, T.T. Tsu, M.S. Hayden, and J.A. Ledbetter. 1999. Characterization of scFv-Ig constructs generated from the anti-CD20 mAb 1F5 using linker peptides of varying lengths. J. Immunol. 162, 6589-6595.
20 Todorovska, A., R.C. Roovers, O. Dolezal, A.A. Kortt, H.R. Hoogenboom, and P.J. Hudson. 2001. Design and application of diabodies, triabodies and tetrabodies for cancer targeting. J. Immunol. Methods 248, 47-66.   DOI
21 Winter, G., A.D. Griffiths, R.E. Hawkins, and H.R. Hoogenboom. 1994. Making antibodies by phage display technology. Annu. Rev. Immunol. 12, 433-455.   DOI   ScienceOn
22 Young, N.M., C.R. MacKenzie, S.A. Narang, R.P. Oomen, and J.E. Baenziger. 1995. Thermal stabilization of a single-chain Fv antibody fragment by introduction of a disulphide bond. FEBS Lett. 377, 135-139.   DOI   ScienceOn
23 Wu, A.M., G.J. Tan, M.A. Sherman, P. Clarke, T. Olafsen, S.J. Forman, and A.A. Raubitschek. 2001. Multimerization of a chimeric anti-CD20 single-chain Fv-Fc fusion protein is mediated through variable domain exchange. Protein Eng. 14, 1025-1033.   DOI
24 Yamanaka, H.I., T. Inoue, and O. Ikeda-Tanaka. 1996. Chicken monoclonal antibody isolated by a phage display system. J. Immunol. 157, 1156-1162.